USA reiterates Johnson & Johnson vaccine recommendation after clotting – Prime Time Zone


Center for Disease Control and Prevention (CDC) issued a statement stating that the benefits of the immunizer outweigh the ‘rare’ risks

ReutersJohnson & Johnson immunization caused blood clots in women over 50 in the U.S.

The Centers for Disease Control and Prevention (CDC) USA reiterated on Tuesday, 11, that the application of the vaccine against Covid-19 gives Johnson & Johnson it has advantages that outweigh the “rare” risks. The immunizer had already been applied again in the country, after a pause due to the possible formation of clots. In a statement, the CDC stressed that those allergic to some of the ingredients present in the vaccine should not take the dose, but that, except for these exceptions, the product is recommended for all adults over 18 years old. In addition, the Center recalled that citizens should receive the vaccine that is currently available, and all brands applied in the U.S. are currently safe. “However, women under 50, especially, should be aware of the rare risk of low platelet blood clots after vaccination, and that other vaccines against Covid-19 in which this risk has not been observed are available,” he says. statement from the CDC.

* With information from Estadão Content